Exposure to a mild hyperbaric oxygen environment elevates blood pressure

Area of Science:

• Physiology
• Hyperbaric Medicine

Background:

• Blood pressure regulation is crucial for cardiovascular health.
• Mild hyperbaric oxygen therapy (mHBOT) involves exposure to increased atmospheric pressure with supplemental oxygen.
• Understanding mHBOT's effects on blood pressure is essential for therapeutic applications.

Purpose of the Study:

• To investigate the impact of mild hyperbaric oxygen at 1.3 atmospheres absolute (ATA) with 30% oxygen on blood pressure.
• To compare these effects against a control condition of 1 ATA with 20.9% oxygen.

Main Methods:

• Ten healthy adults underwent two trials: a control and an mHBOT trial.
• Each trial involved a 45-minute exposure in a chamber.
• Systolic and diastolic blood pressure, heart rate, and peripheral oxygen saturation were measured.

Main Results:

• Mild hyperbaric oxygen therapy resulted in lower heart rate and higher peripheral oxygen saturation compared to the control.
• A significant change in the ratios of systolic and diastolic blood pressure from pre-measurement was observed after mHBOT.
• No significant change in absolute blood pressure values was noted between the groups during exposure.

Conclusions:

• Mild hyperbaric oxygen therapy shows potential as a method for managing chronic hypotension.
• The observed changes in blood pressure ratios suggest a possible regulatory effect.
• Individuals with hypertension should be monitored carefully when considering mHBOT due to potential implications.